GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Sale Of Business

Apontis Pharma AG (XTER:APPH) Sale Of Business : €0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Apontis Pharma AG Sale Of Business?

Apontis Pharma AG's sale of business for the six months ended in Dec. 2024 was €0.00 Mil. It means Apontis Pharma AG gained €0.00 Mil from selling business. Apontis Pharma AG's sale of business for the trailing twelve months (TTM) ended in Dec. 2024 was €0.00 Mil.

Compared with last quarter (€0.00 Mil in Jun. 2024 ), Apontis Pharma AG gained the same money from selling business in Dec. 2024 (€0.00 Mil).

Apontis Pharma AG Sale Of Business Historical Data

The historical data trend for Apontis Pharma AG's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Apontis Pharma AG Sale Of Business Chart

Apontis Pharma AG Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Business
Get a 7-Day Free Trial - - - - -

Apontis Pharma AG Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Apontis Pharma AG Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apontis Pharma AG Sale Of Business Related Terms

Thank you for viewing the detailed overview of Apontis Pharma AG's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Apontis Pharma AG Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Apontis Pharma AG (XTER:APPH) » Definitions » Sale Of Business
Comparable Companies
XTER:B8FK ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD NSE:DIVISLAB HKSE:03692 XSWX:SDZ XTAE:TEVA SHSE:688506 BOM:500087 TSE:4507 SZSE:000538 UTHR NSE:TORNTPHARM BOM:543904 BOM:500124 BOM:500257
Traded in Other Exchanges
N/A
Address
Rolf-Schwarz-Schutte-Platz 1, Monheim, BY, DEU, 40789
Website
https://www.apontis-pharma.de
Apontis Pharma AG is a pharmaceutical company specializing in single pills in Germany. single pills combine two to three generic active ingredients in a single dosage form. The company develops, promotes, and sells a broad portfolio of single pills and other pharmaceutical products, with a special focus on cardiovascular diseases. The company markets drugs in the disease areas of respiratory diseases and diabetes as part of co-marketing/co-promotion.
Executives
Bruno Wohlschlegel Board of Directors
Thomas Milz Board of Directors
Thomas Zimmermann Chief Financial Officer
Karlheinz Gast Board of Directors

Apontis Pharma AG Headlines

No Headlines